Clinical Trial Update: Chemotherapy Combined With Targeted Therapy as First-line Treatment for Mantle Cell Lymphoma Based on MRD and PET-CT Assessment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy combined with targeted therapy as first-line treatment for Mantle Cell Lymphoma, with MRD and PET-CT assessment; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Chemotherapy Combined With Targeted Therapy (unnamed regimen)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING